News
![Generic Launch of Rozerem](https://www.carlislemedical.com/wp-content/uploads/2019/07/Generic-Launch-of-Rozerem.jpg)
![Generic Launch of Rozerem](https://www.carlislemedical.com/wp-content/uploads/2019/07/Generic-Launch-of-Rozerem.jpg)
Generic Launch of Rozerem
The generic equivalent of Rozerem (Ramelteon) is now available. Rozerem is FDA approved for the…
![Launch of Generic Lyrica](https://www.carlislemedical.com/wp-content/uploads/2019/06/Launch-of-Generic-Lyrica.jpg)
![Launch of Generic Lyrica](https://www.carlislemedical.com/wp-content/uploads/2019/06/Launch-of-Generic-Lyrica.jpg)
Launch of Generic Lyrica
The U.S. Food and Drug Administration (FDA) has approved the launch of generic Lyrica (pregabalin)….
![Drug Patents Expiring in 2019](https://www.carlislemedical.com/wp-content/uploads/2019/07/Drug-Patents-Expiring-in-2019.jpg)
![Drug Patents Expiring in 2019](https://www.carlislemedical.com/wp-content/uploads/2019/07/Drug-Patents-Expiring-in-2019.jpg)
Drug Patents Expiring in 2019
The list below is comprised of prescription medications slated for drug patent expirations in 2019….
![Generic Drug Release dates for 2018](https://www.carlislemedical.com/wp-content/uploads/2018/02/2018-Generic-Release.png)
![Generic Drug Release dates for 2018](https://www.carlislemedical.com/wp-content/uploads/2018/02/2018-Generic-Release.png)
Drug Patents Expiring in 2018
The list below is comprised of prescription medications slated for drug patent expirations in 2018….